Kanabo Group (LON:KNB) Stock Price Down 23.3% – Here’s Why

Shares of Kanabo Group Plc (LON:KNB) traded down 23.3% during trading on Monday . The stock traded as low as GBX 0.92 ($0.01) and last traded at GBX 0.92 ($0.01). 1,566,646 shares changed hands during trading, an increase of 244% from the average session volume of 454,771 shares. The stock had previously closed at GBX 1.20 ($0.02).

Kanabo Group Price Performance

The stock has a market capitalization of £5.82 million, a PE ratio of -120.00 and a beta of 3.04. The firm’s 50 day simple moving average is GBX 1.18 and its 200 day simple moving average is GBX 1.40. The company has a debt-to-equity ratio of 3.49, a current ratio of 2.78 and a quick ratio of 24.36.

Insider Transactions at Kanabo Group

In other news, insider Ian Mattioli bought 150,000 shares of the business’s stock in a transaction dated Tuesday, August 27th. The shares were purchased at an average price of GBX 1 ($0.01) per share, for a total transaction of £1,500 ($1,947.55). Company insiders own 37.01% of the company’s stock.

Kanabo Group Company Profile

Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain.